Skip to main content
RavenQuest BioMed Inc. logo

RavenQuest BioMed Inc. — Investor Relations & Filings

Ticker · RVVQF ISIN · CA7543871080 LEI · 549300CUXUE9KESFFW09 CSE Agriculture, forestry and fishing
Open in API
Filings indexed 10 across all filing types
Latest filing 2020-04-14 Regulatory Filings
Country CA Canada
Listing CSE RVVQF

About RavenQuest BioMed Inc.

http://www.rqbglobal.com

RavenQuest BioMed Inc. is a diversified company operating within the cannabis sector. The company's core business activities include cannabis production, management services, and consulting. It also focuses on specialized research and development, often leveraging proprietary technologies to enhance cultivation and processing methods. RavenQuest aims to build a leading diversified cannabis products and services enterprise.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a biweekly status update from RavenQuest BioMed Inc. regarding the delay in filing its annual financial statements and management's discussion and analysis (MD&A) for the fiscal year ended October 31, 2019. It mentions the company's intention to file these annual filings by May 1, 2020, and discusses compliance with National Policy 12-203 related to management cease trade orders. The document does not contain the actual annual report or financial statements but is an update on the filing status and regulatory compliance. The document length is 4432 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about the delay and status of the annual filings, not the filings themselves.
2020-04-14 English
Notice of the meeting and record date (amended) - English.pdf
AGM Information Classification · 95% confidence The document is a confirmation notice from TSX Trust Company regarding the record and meeting dates for the Annual General and Special Meeting of Security Holders of RavenQuest Biomed Inc. It includes details such as the meeting date, record date, and voting information. The document does not contain any financial data, management discussion, or detailed report content. It is a notification about the scheduling and logistics of the upcoming AGM, not the AGM materials themselves or the results of the meeting. The document length is short (2040 characters), and it serves as an announcement rather than a report. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or AGM Information (AGM-R). However, since it is about confirming notice and meeting dates rather than the AGM materials or voting results, it is more aligned with AGM Information (AGM-R).
2020-04-01 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from a law firm providing consent and legal opinions related to a Pricing Supplement for a financial product (Bank of Montreal European Callable Equity Income Principal At Risk Notes). It references a Pricing Supplement dated March 6, 2020, which is an update to a Short Form Base Shelf Prospectus. The content is legal in nature, confirming no misrepresentations in the Pricing Supplement, and is addressed to multiple securities commissions. The document length is short (1764 characters), and it does not contain financial statements or detailed financial data. It is not an actual report but a legal consent letter related to a financing document. Therefore, it fits best under Regulatory Filings (RNS), which covers legal and compliance documents that do not fit other categories.
2020-03-07 English
Notice of the meeting and record date - English.pdf
AGM Information Classification · 95% confidence The document is a confirmation notice from TSX Trust Company regarding the record and meeting dates for the Annual General and Special Meeting of Security Holders of RavenQuest Biomed Inc. It specifies the meeting date, record date, classes of securities entitled to vote, and proxy material delivery details. The document does not contain any financial data, management discussion, or detailed report content. It is essentially an announcement about the scheduling and logistics of the upcoming AGM. Given the short length (1715 characters) and the nature of the content, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or about the Annual General Meeting, or related notices about the AGM. It is not a report publication announcement since it does not mention the release or availability of a report, but rather confirms meeting dates and proxy material distribution. Therefore, the appropriate classification is AGM Information (AGM-R).
2020-02-26 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated February 12, 2020, providing an update on RavenQuest BioMed Inc.'s business plans, including hiring an advisory firm for convertible debentures, staffing reductions, lease renegotiations, legal counsel engagement, and acquisition integration. It discusses operational and strategic updates but does not contain financial statements or detailed financial data. The document is a business update announcement rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update as it lacks substantive financial data or results. It is also not a regulatory filing or certification. The content aligns best with a general Regulatory Filing (RNS) as a miscellaneous business update announcement that does not fit other specific categories.
2020-02-13 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a corporate update from RavenQuest BioMed Inc. dated January 28, 2020. It provides a detailed overview of the company's business plans, technology developments, consulting activities, environmental and governance initiatives, and other operational updates. There are no financial statements, quarterly or annual results, or audit information presented. The document is not a transcript of a call, nor does it announce voting results, dividends, or capital changes. It is a narrative business update aimed at informing shareholders and the public about the company's current status and future plans. This type of document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements and updates that do not fit other specific categories.
2020-01-30 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.